Case File
efta-efta00713231DOJ Data Set 9OtherFrom: "Barrett, Paul S"
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00713231
Pages
2
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: "Barrett, Paul S"
To: Jeffrey Epstein <[email protected]>
CC: "Giuffrida, David J"
Subject: RE: To Do
Date: Thu, 06 Sep 2012 14:05:41 +0000
We ended up selling the BAFC mortgage for 73.00 — we made 250K or 15% in 4 months
Paul Barrett, CFA
Managing Director
Global Investment Opportunities Group
JPMorgan Private Bank
2)A Dante Avonna
lath rinnr
NMLS ID# 853441
Now York, NY 10022
F)
From: Jeffrey Epstein [[email protected]]
Sent: Thursday, September 06, 2012 10:03 AM
To: Barrett, Paul S
Subject: Re: To Do
tlak tomorow
On Thu, Sep 6, 2012 at 9:59 AM, Barrett, Paul S <
> wrote:
Hi Jeffrey
We like the idea of receiving fixed in forward starting interest rate swaps in Europe. The deleveraging process in Europe
will take years which will likely keep short dated rates low for an extended period of time. We would receive fixed in a lyr
interest rate swap starting in 3yrs at 1.33%. Would do 100MM notional which gives you exposure of 10K per basis point.
Positive carry on this trade would be around 490K per year. Collateral of 1%.
Let me know
Paul
Paul Barrett, CFA
Managing Director
Global Investment Opportunities Group
lPMorgan Private Bank
320 Park Avenue. 14th Floor, New York, NY 10022
F)
NMLS ID# 853441
This email is confidential and subject to important disclaimers and conditions including on offers for the purchase or sale of securities. accuracy and completeness of
information. viruses. confidentiality. legal privilege, and legal entity disclaimers. available at http:/www.j
rizan.com'pagcs,'d iscleccurcs.,cmail.
EFTA00713231
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected], and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
This email is confidential and subject to important disclaimers and conditions including on offers for the
purchase or sale of securities, accuracy and completeness of information, viruses, confidentiality, legal privilege,
and legal entity disclaimers, available at http://www.jpmorgan.com/pages/disclosures/email.
EFTA00713232
Technical Artifacts (4)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Domain
rizan.comEmail
[email protected]Email
[email protected]URL
http://www.jpmorgan.com/pages/disclosures/emailRelated Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.